N. Lan

766 citations

74 papers · 438 indexed · h-index 11

Impact in

Cardiology and Cardiovascular Medicine top 10%
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
Sensory Systems top 10%
- Hearing, Cochlea, Tinnitus, Genetics

Papers in ⓘ

Cardiology and Cardiovascular Medicine 40
- Acute Myocardial Infarction Research 11
- Cardiovascular Function and Risk Factors 9
- Heart Failure Treatment and Management 6
Endocrinology, Diabetes and Metabolism 28
- Diabetes Treatment and Management 16
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Diabetes Management and Research 8

Co-authors: P. Gerry Fegan (25 shared papers)Girish Dwivedi (33 shared papers)Bu B. Yeap (19 shared papers)Damon A. Bell (13 shared papers)Gerald F. Watts (17 shared papers)James M. Rankin (14 shared papers)Abdul Rahman Ihdayhid (17 shared papers)Matthew Knuiman (1 shared paper)
Journals: Current Opinion in Endocrinology Diabetes and Obesity (3 papers)Journal of Diabetes and its Complications (2 papers)Emergency Medicine Australasia (2 papers)American Journal of Physiology-Heart and Circulatory Physiology (2 papers)Heart Lung and Circulation (10 papers)
Partner nations: Australia United Kingdom Canada

In The Last Decade

N. Lan

60 papers receiving 433 citations

Peers

Countries citing papers authored by N. Lan

Since Specialization

Citations

This map shows the geographic impact of N. Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Lan more than expected).

Fields of papers citing papers by N. Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Lan. The network helps show where N. Lan may publish in the future.

Co-authors

The 25 scholars most cited alongside N. Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Lan Line = papers co-authored together N. Lan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Associations between cardiovascular disease and its risk factors with hearing loss—A cross‐sectional analysis Clinical Otolaryngology ·Hsern Ern I. Tan, N. Lan, Matthew Knuiman, Mark Divitini, De Wet Swanepoel, Michael Hunter, Christopher G. Brennan‐Jones, Jinyi Hung, Robert H. Eikelboom, P L Santa Maria	2017	70
2	The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Left Ventricular Function: Current Evidence and Future Directions ESC Heart Failure ·N. Lan, P. Gerry Fegan, Bu B. Yeap, Girish Dwivedi	2019	61
3	Evaluation of an artificial intelligence coronary artery calcium scoring model from computed tomography European Radiology ·Abdul Rahman Ihdayhid, N. Lan, Michelle C. Williams, David E. Newby, Julien Flack, Simon C.M. Kwok, Jack Joyner, Sahil Gera, L. Dembo, Brendan Adler, Brian Ko, Benjamin J.W. Chow, Girish Dwivedi	2022	33
4	Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes International journal of cardiac imaging ·N. Lan, Bu B. Yeap, P. Gerry Fegan, Gillian Green, James M. Rankin, Girish Dwivedi	2020	24
5	Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice PubMed ·N. Lan, Damon A. Bell	2019	19
6	Implementing simple algorithms to improve glucose and lipid management in people with diabetes and acute coronary syndrome Diabetic Medicine ·N. Lan, P. Gerry Fegan, Jamie Rankin, Damon A. Bell, Gerald F. Watts, Bu B. Yeap	2019	15
7	Characteristics and Outcomes of Young Patients With ST-Elevation Myocardial Infarction Without Standard Modifiable Risk Factors The American Journal of Cardiology ·Ciaran Kelly, N. Lan, Jane Phan, Cherng Hng, Amy Matthews, James M. Rankin, Carl Schultz, Graham S. Hillis, Christopher M. Reid, Girish Dwivedi, Gemma A. Figtree, Abdul Rahman Ihdayhid	2023	13
8	Artificial Intelligence in Cardiology: An Australian Perspective Heart Lung and Circulation ·Biyanka Jaltotage, Abdul Rahman Ihdayhid, N. Lan, Faraz Pathan, Sanjay V. Patel, Clare Arnott, Gemma A. Figtree, Leonard Kritharides, Syed Mohammed Shamsul Islam, Clara K Chow, James M. Rankin, Stephen J. Nicholls, Girish Dwivedi	2023	12
9	Improving the detection of familial hypercholesterolaemia Pathology ·N. Lan, Andrew C. Martin, Tom Brett, Gerald F. Watts, Damon A. Bell	2018	12
10	The Impact of Distinct Exercise Training Modalities on Echocardiographic Measurements in Patients with Heart Failure with Reduced Ejection Fraction Journal of the American Society of Echocardiography ·N. Lan, Kaitlyn Lam, Louise H. Naylor, Daniel J. Green, Novia Minaee, Peter Dias, Andrew Maiorana	2019	12
11	High‐Sensitivity Cardiac Troponin I Improves Cardiovascular Risk Prediction in Older Men: HIMS (The Health in Men Study) Journal of the American Heart Association ·N. Lan, Damon A. Bell, Kieran McCaul, Samuel D Vasikaran, Bu B. Yeap, Paul E. Norman, Osvaldo P. Almeida, Jonathan Golledge, Graeme J. Hankey, Leon Flicker	2019	12
12	Recent advances in the management and implementation of care for familial hypercholesterolaemia Pharmacological Research ·N. Lan, Archna Bajaj, Gerald F. Watts, Marina Cuchel	2023	9
13	Dyslipidaemia in adults with type 1 diabetes—when to treat? Diabetes/Metabolism Research and Reviews ·N. Lan, P. Gerry Fegan, Bu B. Yeap, Damon A. Bell, Gerald F. Watts	2018	8
14	A case of vascular Ehlers-Danlos Syndrome with a cardiomyopathy and multi-system involvement Cardiovascular Pathology ·N. Lan, Michael Fietz, Nicholas Pachter, Vincent Paul, David Playford	2018	7
15	Unravelling the cardio-renal-metabolic-foot connection in people with diabetes-related foot ulceration: a narrative review Cardiovascular Diabetology ·N. Lan, Girish Dwivedi, P. Gerry Fegan, Frances L. Game, Emma Hamilton	2024	7
16	Lipoprotein(a) in Patients With Type 2 Diabetes and Premature Coronary Artery Disease in the Coronary Care Unit Heart Lung and Circulation ·N. Lan, Dick C. Chan, Jing Pang, P. Gerry Fegan, Bu B. Yeap, James M. Rankin, Carl Schultz, Gerald F. Watts, Damon A. Bell	2020	7
17	Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetes Current Opinion in Endocrinology Diabetes and Obesity ·N. Lan, Damon A. Bell, Gerald F. Watts, P. Gerry Fegan	2022	7
18	Contemporary Chest Pain Evaluation: The Australian Case for Cardiac CT Heart Lung and Circulation ·Abdul Rahman Ihdayhid, N. Lan, Gemma A. Figtree, Sanjay Patel, Clare Arnott, Christian Hamilton‐Craig, Peter J. Psaltis, Jonathon Leipsic, Timothy Fairbairn, S. Wahi, Graham S. Hillis, James M. Rankin, Girish Dwivedi, Stephen J. Nicholls	2023	6
19	Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia Metabolism ·G. Huangfu, Biyanka Jaltotage, Jing Pang, N. Lan, Arun Abraham, Jacobus Otto, Abdul Rahman Ihdayhid, James M. Rankin, Benjamin J.W. Chow, Gerald F. Watts, Oyekoya T. Ayonrinde, Girish Dwivedi	2022	6
20	Investigating the effect of an education programme on diabetes and lipid lowering medication usage following coronary artery bypass graft surgery Internal Medicine Journal ·Sarah A. Hitchen, N. Lan, Umar Ali, Adam Hort, Robert Larbalestier, Bu B. Yeap, P. Gerry Fegan	2021	5

About N. Lan

N. Lan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Health Informatics, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 74 papers that have together received 438 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (16 papers), Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Acute Myocardial Infarction Research (11 papers), Cardiac Imaging and Diagnostics (10 papers), Cardiovascular Function and Risk Factors (9 papers), Diabetes Management and Research (8 papers) and Heart Failure Treatment and Management (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (217 citations), Sensory Systems (43 citations), Endocrinology, Diabetes and Metabolism (144 citations), Health Informatics (11 citations) and Speech and Hearing (31 citations). N. Lan has collaborated with scholars based in Australia, United Kingdom and Canada. Frequent co-authors include P. Gerry Fegan, Girish Dwivedi, Bu B. Yeap, Damon A. Bell, Gerald F. Watts, James M. Rankin, Abdul Rahman Ihdayhid, Matthew Knuiman, Michael Hunter and Mark Divitini. Their work appears in journals such as Current Opinion in Endocrinology Diabetes and Obesity, Journal of Diabetes and its Complications, Emergency Medicine Australasia, American Journal of Physiology-Heart and Circulatory Physiology and Heart Lung and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact